MARKET

BMY

BMY

Bristol-Myers Squibb Co
NYSE
59.46
-0.09
-0.15%
After Hours: 59.10 -0.36 -0.60% 19:44 05/22 EDT
OPEN
59.97
PREV CLOSE
59.55
HIGH
60.25
LOW
59.25
VOLUME
6.49M
TURNOVER
--
52 WEEK HIGH
62.24
52 WEEK LOW
41.46
MARKET CAP
121.42B
P/E (TTM)
16.69
1D
5D
1M
3M
1Y
5Y
1D
Looking to Buy Bristol Myers Squibb Stock on the Dip? Read This First.
The Motley Fool · 10h ago
How Bristol Myers Squibb’s Claude AI Deployment Across its Pipeline (BMY) Has Changed Its Investment Story
Simply Wall St · 18h ago
Market View
Barron‘s · 1d ago
Bristol-Myers Squibb snaps six straight sessions of gains
Seeking Alpha · 2d ago
Catalyst Watch: Fedspeak ramps up post-Powell, core PCE, and box office blitz
Seeking Alpha · 2d ago
Bristol-Myers Squibb Stock Rises on Anthropic AI Deal. Why This Could Actually Be a Key Upside Catalyst.
Barchart · 2d ago
Bristol Myers Squibb AI Deal With Anthropic And What It Means For BMY
Simply Wall St · 2d ago
AGEN Stock Dips 19.4% in a Month: Time to Buy, Hold or Sell?
NASDAQ · 3d ago
More
About BMY
Bristol-Myers Squibb Company is a global biopharmaceutical company. It is engaged in the discovery, development, and delivery of transformational medicines for patients facing serious diseases in areas: oncology, hematology, immunology, cardiovascular, neuroscience and other areas. Its growth portfolio includes Opdivo (nivolumab), Opdivo Qvantig (nivolumab and hyaluronidase-nvhy), Orencia (abatacept), Yervoy (ipilimumab), Reblozyl (luspatercept-aamt), Breyanzi (lisocabtagene maraleucel), Opdualag (nivolumab and relatlimab-rmbw), Camzyos (mavacamten), Zeposia (ozanimod), Abecma (idecabtagene vicleucel), Sotyktu (deucravacitinib), Krazati (adagrasib), and Cobenfy (xanomeline and trospium chloride). Its other growth products include Augtyro, Onureg, Inrebic, Nulojix, and Empliciti. Its legacy portfolio includes Eliquis (apixaban), Revlimid (lenalidomide), Pomalyst/Imnovid (pomalidomide), Sprycel (dasatinib), and Abraxane (paclitaxel albumin-bound particles for injectable suspension).

Webull offers Bristol-Myers Squibb Co stock information, including NYSE: BMY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BMY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BMY stock methods without spending real money on the virtual paper trading platform.